The electronic cigarette industry is safe, for now! On April 24, 2014, the U.S. Food & Drug Administration (FDA) released its long-awaited proposed regulations regarding electronic cigarettes. Said regulations are intended to extend the FDA’s authority over tobacco products to include e cigarettes and introduce new guidelines for industry stakeholders.
If the Proposed Rule passes without revision, here’s what could happen:
– E cig manufacturers would be required to register their products with the FDA and disclose specific details about ingredients contained in e-liquid
– Placement and promotion of new tobacco products would only be permitted AFTER review by the FDA
– Distributing free samples of ecig products would be prohibited
– Sales to minors would be strictly prohibited; sellers must enforce the tobacco age requirements for their respective states
– Flavor varieties would not be limited
– Online sales would still be permitted
Here at V2®, we stand behind responsible regulations for the e cig industry:
– We support the FDA’s plans to require lists of ingredients from all manufacturers; the ingredients in V2 Platinum E-Liquids, Disposables and Cartridges can easily be downloaded on the V2 website and customers can have their unique Batch Test results sent directly to their inbox – no other e cig company provides this level of transparency.
Our CEO, J. Andries Verleur, told the media, “We endorse the FDA’s goal of ensuring that e-cigarette products are reliable, safe, and consistent.”
What can you do?
A public comment period is open through July 9, 2014. Here’s what information the FDA is requesting:
“FDA is seeking comments, including supporting research, facts, and other evidence, as to how e-cigarettes should be regulated based on the continuum of nicotine-delivering products and the potential benefits associated with e-cigarettes.”
Click here to submit your formal comment.
To read the press release published by the FDA, click here.
We’ll keep you updated on any new happenings. What are your thoughts about the FDA’s Proposed Rule?